Karmanos Cancer Institute improved its ability to identify high‑risk patients by updating its breast cancer screening questionnaire. Their modified survey helped create a more accurate cancer risk assessment tool.
How Karmanos built a more accurate cancer risk assessment tool
In this article from Becker’s Hospital Review, learn how Karmanos began identifying high-risk cancer patients by modifying their breast cancer patient screening survey questionnaire.
Discover how Risk Pathways™ simplifies breast, endometrial, ovarian, colorectal, pancreatic, and prostate cancer risk assessment to support smarter clinical decisions so you can focus on delivering personalized care.
